Healthcare & Life Science

VitriVax, the developer of a novel stabilization and delivery platform for vaccines and therapeutics, has closed its first institutional financing round with Adjuvant Capital. KO partners Jon Taylor and Brad Schoenfeld, and attorney Matt Burns represented VitriVax in the financing round. The Series A proceeds will be used to develop…

When you have limited dollars for legal issues, it’s important to know where to spend those funds to maximize your company’s investment in legal resources without waste and inefficiency.​ Experienced corporate counsel will tell early stage companies in most industries to focus on two priorities as soon as possible: capital…

Contract Research Organization (CRO) consolidation has become a constant force in the life sciences market. This shifting environment has made protecting clinical trial success and anticipating and planning for CRO consolidation risks critical for pharmaceutical and medical device companies when negotiating agreements. Working with high-performing CROs, with deep industry and…

Koenig, Oelsner, Taylor, Schoenfeld & Gaddis PC (KO Law Firm) is growing. We are currently hiring for four positions: Contracts manager Paralegal Commercial attorney Life sciences attorney KO is an innovative corporate and commercial law firm with a team of experienced lawyers and a practical, efficient, business-focused approach. We have a…

Force majeure, supply chain agreements, commercial contracts and remote customer service — these are just a few of the many areas businesses are rethinking due to the COVID-19 pandemic. For life science companies, these areas take on significant and often urgent meaning as they apply to the pharmaceutical production and…

Today, many have the misperception that M&A deals aren’t getting done because of the ongoing COVID-19 pandemic, or that the only deals closing are distressed deals that are unfavorable to the seller. But there’s more to the story. While we have seen a shift from a seller-favorable market to a…

KO client Nanospectra Biosciences, a medical device company that is pioneering a novel use of nanomedicine to destroy tumors without damaging adjacent healthy tissue, recently closed a $3 million Series B-1 financing with total approved capital of up to $6 million. The financing will be used for additional development and…

Koenig, Oelsner, Taylor, Schoenfeld & Gaddis PC (KO Law Firm) has announced the expansion of its commercial practice with the addition of attorney Christine Hofmeister. Christine counsels health care, life science, technology and professional services clients on a variety of commercial and transactional matters. Christine specializes in drafting and negotiating a wide…